These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 34335466)

  • 1. Human Beta Cell Regenerative Drug Therapy for Diabetes: Past Achievements and Future Challenges.
    Wang P; Karakose E; Choleva L; Kumar K; DeVita RJ; Garcia-Ocaña A; Stewart AF
    Front Endocrinol (Lausanne); 2021; 12():671946. PubMed ID: 34335466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DYRK1A Inhibitors as Potential Therapeutics for β-Cell Regeneration for Diabetes.
    Kumar K; Suebsuwong C; Wang P; Garcia-Ocana A; Stewart AF; DeVita RJ
    J Med Chem; 2021 Mar; 64(6):2901-2922. PubMed ID: 33682417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GLP-1 receptor agonists synergize with DYRK1A inhibitors to potentiate functional human β cell regeneration.
    Ackeifi C; Wang P; Karakose E; Manning Fox JE; González BJ; Liu H; Wilson J; Swartz E; Berrouet C; Li Y; Kumar K; MacDonald PE; Sanchez R; Thorens B; DeVita R; Homann D; Egli D; Scott DK; Garcia-Ocaña A; Stewart AF
    Sci Transl Med; 2020 Feb; 12(530):. PubMed ID: 32051230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of the pancreatic islet-stress axis as a novel potential therapeutic target in diabetes mellitus.
    Ludwig B; Barthel A; Reichel A; Block NL; Ludwig S; Schally AV; Bornstein SR
    Vitam Horm; 2014; 95():195-222. PubMed ID: 24559919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication.
    Wang P; Alvarez-Perez JC; Felsenfeld DP; Liu H; Sivendran S; Bender A; Kumar A; Sanchez R; Scott DK; Garcia-Ocaña A; Stewart AF
    Nat Med; 2015 Apr; 21(4):383-8. PubMed ID: 25751815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in drug discovery for human beta cell regeneration.
    Karakose E; Ackeifi C; Wang P; Stewart AF
    Diabetologia; 2018 Aug; 61(8):1693-1699. PubMed ID: 29770834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regenerative medicine of the pancreatic beta cells.
    Yamada S; Kojima I
    J Hepatobiliary Pancreat Surg; 2005; 12(3):218-26. PubMed ID: 15995810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic Kinome Inhibitors-A New Opportunity for β-Cells Restoration.
    Pucelik B; Barzowska A; Dąbrowski JM; Czarna A
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined Inhibition of DYRK1A, SMAD, and Trithorax Pathways Synergizes to Induce Robust Replication in Adult Human Beta Cells.
    Wang P; Karakose E; Liu H; Swartz E; Ackeifi C; Zlatanic V; Wilson J; González BJ; Bender A; Takane KK; Ye L; Harb G; Pagliuca F; Homann D; Egli D; Argmann C; Scott DK; Garcia-Ocaña A; Stewart AF
    Cell Metab; 2019 Mar; 29(3):638-652.e5. PubMed ID: 30581122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to make insulin-producing pancreatic β cells for diabetes treatment.
    Lu J; Xia Q; Zhou Q
    Sci China Life Sci; 2017 Mar; 60(3):239-248. PubMed ID: 27796637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Induced Pluripotent Stem Cells in the Curative Treatment of Diabetes and Potential Impediments Ahead.
    Dadheech N; James Shapiro AM
    Adv Exp Med Biol; 2019; 1144():25-35. PubMed ID: 30569414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic stem cells remain unresolved.
    Jiang FX; Morahan G
    Stem Cells Dev; 2014 Dec; 23(23):2803-12. PubMed ID: 25132582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DYRK1A Kinase Inhibitors Promote β-Cell Survival and Insulin Homeostasis.
    Barzowska A; Pucelik B; Pustelny K; Matsuda A; Martyniak A; Stępniewski J; Maksymiuk A; Dawidowski M; Rothweiler U; Dulak J; Dubin G; Czarna A
    Cells; 2021 Aug; 10(9):. PubMed ID: 34571911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Customized cell-based treatment options to combat autoimmunity and restore beta-cell function in type 1 diabetes mellitus: current protocols and future perspectives.
    Fändrich F; Ungefroren H
    Adv Exp Med Biol; 2010; 654():641-65. PubMed ID: 20217518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel selective thiadiazine DYRK1A inhibitor lead scaffold with human pancreatic β-cell proliferation activity.
    Kumar K; Man-Un Ung P; Wang P; Wang H; Li H; Andrews MK; Stewart AF; Schlessinger A; DeVita RJ
    Eur J Med Chem; 2018 Sep; 157():1005-1016. PubMed ID: 30170319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regenerative medicine for diabetes: differentiation of human pluripotent stem cells into functional β-cells in vitro and their proposed journey to clinical translation.
    Bose B; Katikireddy KR; Shenoy PS
    Vitam Horm; 2014; 95():223-48. PubMed ID: 24559920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro generation of pancreatic β-cells for diabetes treatment. I. β-like cells derived from human pluripotent stem cells.
    Cierpka-Kmiec K; Wronska A; Kmiec Z
    Folia Histochem Cytobiol; 2019; 57(1):1-14. PubMed ID: 30869153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic stem cells: from possible to probable.
    Jiang FX; Morahan G
    Stem Cell Rev Rep; 2012 Sep; 8(3):647-57. PubMed ID: 22090024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell therapies for pancreatic beta-cell replenishment.
    Okere B; Lucaccioni L; Dominici M; Iughetti L
    Ital J Pediatr; 2016 Jul; 42(1):62. PubMed ID: 27400873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gimmicks of gamma-aminobutyric acid (GABA) in pancreatic β-cell regeneration through transdifferentiation of pancreatic α- to β-cells.
    Yi Z; Waseem Ghani M; Ghani H; Jiang W; Waseem Birmani M; Ye L; Bin L; Cun LG; Lilong A; Mei X
    Cell Biol Int; 2020 Apr; 44(4):926-936. PubMed ID: 31903671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.